Cover Story
Conversation with The Cancer Letter
By Matthew Bin Han Ong
“I think cell therapy is going to continue to be a very, very important treatment modality for cancer, and we would like to see the Tampa Bay area become the cell therapy capital of the universe,” Hwu, the new president and CEO of H. Lee Moffitt Cancer Center, said to The Cancer Letter.
By Alexandria Carolan and Matthew Bin Han Ong
By Alexandria Carolan
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets
Trending Stories
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Karen Knudsen to leave ACS
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72